Join
Live feed
·
INSIDERFilingvia Quantisnow
MaxCyte Inc. logo

Director Hemrajani Rekha sold $22,378 worth of shares (10,684 units at $2.09), decreasing direct ownership by 21% to 39,893 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
MXCT· MaxCyte Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track MXCT (MaxCyte Inc.) and more on Quantisnow.